InvestorsHub Logo

XenaLives

01/07/17 8:43 AM

#4316 RE: shermann7 #4311

Nothing much there that I would disagree with, but I didn't see a proposal for a fundamental solution, did I miss it?

Officials are bracing for runaway inflation that threatens the very existence of their system of bondage.



I think a rational, informed electorate would be a bigger threat, don't you?

Unless we have this the pendulum will continue to swing, which is probably best represented by the election of Trump.

By the way, Anavex 2-73 acts on some of the same receptors in the brain as cannabis. It just finished an adaptive P2 and will be going to P3 in 2017. The initial trial group of 32 is now 25 and they are in a two year extension of the P2 which is being funded by the Australian government. Several trial participants had "unexpected" therapeutic response and disease reversal while on non-optimized P2 dosage. This has never occurred before in Alzheimer's.

From a recent presentation, full presentation on Anavex site: